Pattern of mutations that results in loss of reduced folate carrier function under antifolate selective pressure augmented by chemical mutagenesis

Molecular Pharmacology

Volumn 56, Issue 1, 1999, Pages 68-76

  Zhao, Rongbao ^a   Sharina, Iraida G ^a   Goldman, I David ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; FOLIC ACID; FOLIC ACID ANTAGONIST; GLYCINE; MESSENGER RNA; SERINE;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CHEMICAL MUTAGENESIS; CONTROLLED STUDY; DRUG RESISTANCE; DRUG TRANSPORT; LEUKEMIA L 1210; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; SEQUENCE ANALYSIS; STRUCTURE ACTIVITY RELATION;

EID: 0033057285     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.56.1.68     Document Type: Article

References (40)

1. Brigle KE, Spinella MJ, Sierra EE and Goldman ID (1995) Characterization of a mutation in the reduced folate carrier in a transport defective L1210 murine leukemia cell line. J Biol Chem 270:22974-22979.
2. Caspari T, Stadler R, Sauer N and Tanner W (1994) Structure/function relationship of the Chlorella glucose/H+ symporter. J Biol Chem 269:3498-3502.
3. Conradt M and Stoffel W (1995) Functional analysis of the high affinity, Na(+)-dependent glutamate transporter GLAST-1 by site-directed mutagenesis. J Biol Chem 270:25207-25212.
4. Cowan KH and Jolivet J (1984) A methotrexate-resistant human breast cancer cell line with multiple defects, including diminished formation of methotrexate polyglutamates. J Biol Chem 259:10793-10800.
5. Dixon KH, Lanpher BC, Chiu J, Kelley K and Cowan KH (1994) A novel cDNA restores reduced folate carrier activity and methotrexate sensitivity to transport deficient cells. J Biol Chem 269:17-20.
6. Goldman ID (1971) The characteristics of the membrane transport of amethopterin and the naturally occurring folates. Ann NY Acad Sci 186:400-422.
7. Gorlick R, Goker E, Trippett T, Steinherz P, Elisseyeff Y, Mazuradar M, Flintoff WF and Bertino JR (1997) Defective transport is a common mechanism of acquired methotrexate resistance in acute lymphocytic leukemia and is associated with decreased reduced folate carrier expression. Blood 89:1013-1018.
8. Heidkamper D, Muller V, Nelson DR and Klingenberg M (1996) Probing the role of positive residues in the ADP/ATP carrier from yeast. The effect of six arginine mutations on transport and the four ATP versus ADP exchange modes. Biochemistry 35:16144-16152.
9. Henderson GB and Zevely EM (1983) Structural requirements for anion substrates of the methotrexate transport system of L1210 cells. Arch Biochem Biophys 221: 438-446.
10. Jackman AL and Calvert AH (1995) Folate-based thymidylate synthase inhibitors as anticancer drugs. Ann Oncol 6:871-881.
11. Jansen G, Mauritz R, Drori S, Sprecher H, Kathmann I, Bunni M, Priest DG, Noordhuis P, Schornagel JH, Pinedo HM, Peters GJ and Assaraf YG (1998) A structurally altered human reduced folate carrier with increased folic acid transport mediates a novel mechanism of antifolate resistance. J Biol Chem 273:30189-30198.
12. Karbach D, Staub M, Wood PG and Passow H (1998) Effect of site-directed mutagenesis of the arginine residues 509 and 748 on mouse band 3 protein-mediated anion transport. Biochim Biophys Acta 1371:114-122.
13. Lee GS, Blonsky KS, Van On DL, Savage EA, Morgan AR and von Borstel RC (1992) Base alterations in yeast induced by alkylating agents with differing Swain-Scott substrate constants. J Mol Biol 223:617-626.
14. Matherly LH, Taub JW, Ravindranath Y, Proefke SA, Wong SC, Gimotty P, Buck S, Wright JE and Rosowsky A (1995) Elevated dihydrofolate reductase and impaired methotrexate transport as elements in methotrexate resistance in childhood acute lymphoblastic leukemia. Blood 85:500-509.
15. Mendelsohn LG, Shih C, Schultz RM and Worzalla JF (1996) Biochemistry and pharmacology of glycinamide ribonucleotide formyltransferase inhibitors: LY309887 and lometrexol. Invest New Drugs 14:287-294.
16. Moscow JA, Gong MK, He R, Sgagias MK, Dixon KH, Anzick SL, Meltzer PS and Cowan KH (1995) Isolation of a gene encoding a human reduced folate carrier (RFC1) and analysis of its expression in transport-deficient, methotrexate-resistant human breast cancer cells. Cancer Res 55:3790-3794.
17. Oka Y, Asano T, Shibasaki Y, Lin JL, Tsukuda K, Katagiri H, Akanuma Y and Takaku F (1990) C-terminal truncated glucose transporter is locked into an inward-facing form without transport activity. Nature (Lond) 345:550-553.
18. Pao SS, Paulsen IT and Saier MH, Jr (1998) Major facilitator superfamily. Micrabiol Mol Biol Rev 62:1-34.
19. Prasad PD, Ramamoorthy S, Leibach FH and Ganapathy V (1995) Molecular cloning of the human placental folate transporter Biochem Biophys Res Commun 206: 681-687.
20. Pui CH and Evans WE (1998) Acute lymphoblastic leukemia. N Engl J Med 339: 605-615.
21. Rosowsky A, Lazarus H, Yuan GC, Beltz WR, Mangini L, Abelson HT, Modest EJ and Frei E 3d (1980) Effects of methotrexate esters and other lipophilic antifolates on methotrexate-resistant human leukemic lymphoblasts. Biochem Pharmacol 29:648-652.
22. Roy K, Tolner B, Chiao JH and Sirotnak FM (1998) A single amino acid difference within the folate transporter encoded by the murine RFC-1 gene selectively alters its interaction with folate analogues. Implications for intrinsic antifolate resistance and directional orientation of the transporter within the plasma membrane of tumor cells. J Biol Chem 273:2526-2531.
23. Schuetz JD, Matherly LH, Westin EH and Goldman ID (1988) Evidence for a functional defect in the translocation of the methotrexate transport carrier in a methotrexate-resistant murine L1210 leukemia cell line. J Biol Chem 263:9840-9847.
24. Shih C, Habeck LL, Mendelsohn LG, Chen VJ and Schultz RM (1998) Multiple folate enzyme inhibition: Mechanism of a novel pyrrolopyrimidine-based antifolate LY231514. Adv Enzyme Regul 38:135-152.
25. Sirotnak FM, Goutas LJ and Mines LS (1985) Extent of the requirement for folate transport by L1210 cells for growth and leukemogenesis in vivo. Cancer Res 45:4732-4734.
26. Sirotnak FM, Moccio DM, Kelleher LE and Goutas LJ (1981) Relative frequency and kinetic properties of transport-defective phenotypes among methotrexate-resistant L1210 clonal cell lines derived in vivo. Cancer Res 41:4447-4452.
27. Trippett T, Schlemmer S, Elisseyeff Y, Goker E, Wachter M, Steinherz P, Tan C, Berman E, Wright JE, Rosowsky A, Schweitzer B and Bertino JR (1992) Defective transport as a mechanism of acquired resistance to methotrexate in patients with acute lymphocytic leukemia. Blood 80:1158-1162.
28. Tse A, Brigle K, Taylor SM and Moran RG (1998) Mutations in the reduced folate carrier gene which confer dominant resistance to 5,10-dideazatetrahydrofolate. J Biol Chem 273:25953-25960.
29. Underhill TM and Flintoff WF (1989) Complementation of a methotrexate uptake defect in Chinese hamster ovary cells by DNA-mediated gene transfer. Mol Cell Biol 9:1754-1758.
30. Williams FMR and Flintoff WF (1995) Isolation of a human cDNA that complements a mutant hamster cell defective in methotrexate uptake. J Biol Chem 270:2987-2992.
31. Williams FMR, Murray RC, Underhill TM and Flintoff WF (1994) Isolation of a hamster cDNA clone coding for a function involved in methotrexate uptake. J Biol Chem 269:5810-5816.
32. Williams KA and Deber CM (1991) Proline residues in transmembrane helices: Structural or dynamic role? Biochemistry 30:8919-8923.
33. Wong SC, Proefke SA, Bhushan A and Matherly LH (1995) Isolation of human cDNAs that restore methotrexate sensitivity and reduced folate carrier activity in methotrexate transport-defective Chinese hamster ovary cells. J Biol Chem 270: 17468-17475.
34. Yan BX and Sun YQ (1997) Glycine residues provide flexibility for enzyme active sites. J Biol Chem 272:3190-3194.
35. Yang C-H, Dembo M and Sirotnak FM (1983) Relationships between carrier-mediated transport of folate compounds by L1210 leukemia cells: Evidence for multiplicity of entry routes with different kinetic properties expressed in plasma membrane vesicles. J Membr Biol 75:11-20.
36. Yang C-H, Sirotnak FM and Dembo M (1984) Interaction between anions and the reduced folate/methotrexate transport system in L1210 cell plasma membrane vesicles: Directional symmetry and anion specificity for differential mobility of loaded and unloaded carrier. J Membr Biol 79:285-292.
37. Zhang L, Taub JW, Williamson M, Wong SC, Hukku B, Pullen J, Ravindranath Y and Matherly LH (1998) Reduced folate carrier gene expression in childhood acute lymphoblastic leukemia: Relationship to immunophenotype and ploidy. Clin Cancer Res 4:2169-2177.
38. Zhao R, Assaraf YG and Goldman ID (1998a) A reduced carrier mutation produces substrate-dependent alterations in carrier mobility in murine leukemia cells and methotrexate resistance with conservation of growth in 5-formyltetrahydrofolate. JBM Chem 378:7873-7879.
39. Zhao R, Assaraf YG and Goldman ID (1998b) A mutated murine reduced folate carrier (RFC1) with increased affinity for folic acid, decreased affinity for methotrexate, and an obligatory anion requirement for transport function. J Biol Chem 273:19065-19071.
40. Zhao R, Seither R, Brigle KE, Sharina IG, Wang PJ and Goldman ID (1997) Impact of overexpression of the reduced folate carrier (RFC1), an anion exchanger, on concentrative transport in murine L1210 leukemia cells. J Biol Chem 272:21207-21212.